1. Reiman EM. Alzheimer disease in 2016: Putting AD treatments and biomarkers to the test. Nat Rev Neurol. 2017;13(2):74-6.
2. The Lancet N. Alzheimer's disease: a time for cautious optimism. Lancet Neurol. 2015;14(8):779.
3. The Lancet N. Finding a cure for Alzheimer's disease starts with prevention. Lancet Neurol. 2016;15(7):649.
4. Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science. 2002;297(5580):353-6.
5. Deardorff WJ, Grossberg GT. Targeting neuroinflammation in Alzheimer's disease: evidence for NSAIDs and novel therapeutics. Expert Rev Neurother. 2017;17(1):17-32.
6. Hansen DV, Hanson JE, Sheng M. Microglia in Alzheimer's disease. J Cell Biol. 2018;217(2):459-72.
7. Gosselin D, Skola D, Coufal NG, Holtman IR, Schlachetzki JCM, Sajti E, et al. An environment-dependent transcriptional network specifies human microglia identity. Science. 2017;356(6344).
8. Prinz M, Priller J. Microglia and brain macrophages in the molecular age: from origin to neuropsychiatric disease. Nat Rev Neurosci. 2014;15(5):300-12.
9. Müller S, Kohanbash G, Liu SJ, Alvarado B, Carrera D, Bhaduri A, et al. Single-cell profiling of human gliomas reveals macrophage ontogeny as a basis for regional differences in macrophage activation in the tumor microenvironment. Genome Biol. 2017;18(1):234.
10. Hanisch UK, Kettenmann H. Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat Neurosci. 2007;10(11):1387-94.
11. Cai Z, Hussain MD, Yan LJ. Microglia, neuroinflammation, and beta-amyloid protein in Alzheimer's disease. Int J Neurosci. 2014;124(5):307-21.
12. Olsen I, Singhrao SK. Inflammasome Involvement in Alzheimer's Disease. J Alzheimers Dis. 2016;54(1):45-53.
13. Karki R, Man SM, Kanneganti TD. Inflammasomes and Cancer. Cancer Immunol Res. 2017;5(2):94-9.
14. van de Veerdonk FL, Joosten LA, Netea MG. The interplay between inflammasome activation and antifungal host defense. Immunol Rev. 2015;265(1):172-80.
15. Man SM, Kanneganti TD. Regulation of inflammasome activation. Immunol Rev. 2015;265(1):6-21.
16. Palomo J, Dietrich D, Martin P, Palmer G, Gabay C. The interleukin (IL)-1 cytokine family--Balance between agonists and antagonists in inflammatory diseases. Cytokine. 2015;76(1):25-37.
17. Gordon R, Albornoz EA, Christie DC, Langley MR, Kumar V, Mantovani S, et al. Inflammasome inhibition prevents α-synuclein pathology and dopaminergic neurodegeneration in mice. Sci Transl Med. 2018;10(465).
18. Krasemann S, Madore C, Cialic R, Baufeld C, Calcagno N, El Fatimy R, et al. The TREM2-APOE Pathway Drives the Transcriptional Phenotype of Dysfunctional Microglia in Neurodegenerative Diseases. Immunity. 2017;47(3):566-81.e9.
19. Dubois B, Feldman HH, Jacova C, Dekosky ST, Barberger-Gateau P, Cummings J, et al. Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria. Lancet Neurol. 2007;6(8):734-46.
20. Liu Y, Yuelling LW, Wang Y, Du F, Gordon RE, O'Brien JA, et al. Astrocytes Promote Medulloblastoma Progression through Hedgehog Secretion. Cancer Res. 2017;77(23):6692-703.
21. Brett FM, Kearney H. Neuropathology correlates of cognitive assessments. Ir J Med Sci. 2018;187(3):835-44.
22. Wei Y, Feng J, Hou Z, Wang XM, Yu D. Flow cytometric analysis of circulating follicular helper T (Tfh) and follicular regulatory T (Tfr) populations in human blood. Methods Mol Biol. 2015;1291:199-207.
23. Wimo A. The End of the Beginning of the Alzheimer's Disease Nightmare: A Devil's Advocate's View. J Alzheimers Dis. 2018;64(s1):S41-s6.
24. Sarlus H, Heneka MT. Microglia in Alzheimer's disease. J Clin Invest. 2017;127(9):3240-9.
25. Jaroudi W, Garami J, Garrido S, Hornberger M, Keri S, Moustafa AA. Factors underlying cognitive decline in old age and Alzheimer's disease: the role of the hippocampus. Rev Neurosci. 2017;28(7):705-14.
26. Malik A, Kanneganti TD. Inflammasome activation and assembly at a glance. J Cell Sci. 2017;130(23):3955-63.
27. Bajo-Grañeras R, Sanchez D, Gutierrez G, González C, Do Carmo S, Rassart E, et al. Apolipoprotein D alters the early transcriptional response to oxidative stress in the adult cerebellum. J Neurochem. 2011;117(6):949-60.
28. Li L, Liu MS, Li GQ, Tang J, Liao Y, Zheng Y, et al. Relationship between Apolipoprotein Superfamily and Parkinson's Disease. Chin Med J (Engl). 2017;130(21):2616-23.
29. Drew L. An age-old story of dementia. Nature. 2018;559(7715):S2-s3.
30. Kalaria RN, Maestre GE, Arizaga R, Friedland RP, Galasko D, Hall K, et al. Alzheimer's disease and vascular dementia in developing countries: prevalence, management, and risk factors. Lancet Neurol. 2008;7(9):812-26.
31. 2016 Alzheimer's disease facts and figures. Alzheimers Dement. 2016;12(4):459-509.
32. Perlmutter D. Preventing Alzheimer's Disease. J Am Coll Nutr. 2016;35(8):732-3.
33. Salawu FK, Umar JT, Olokoba AB. Alzheimer's disease: a review of recent developments. Ann Afr Med. 2011;10(2):73-9.
34. Lucke-Wold B, Seidel K, Udo R, Omalu B, Ornstein M, Nolan R, et al. Role of Tau Acetylation in Alzheimer's Disease and Chronic Traumatic Encephalopathy: The Way Forward for Successful Treatment. J Neurol Neurosurg. 2017;4(2).
35. Correani V, Martire S, Mignogna G, Caruso LB, Tempera I, Giorgi A, et al. Poly(ADP-ribosylated) proteins in β-amyloid peptide-stimulated microglial cells. Biochem Pharmacol. 2019;167:50-7.
36. Nayak D, Roth TL, McGavern DB. Microglia development and function. Annu Rev Immunol. 2014;32:367-402.
37. Hickman S, Izzy S, Sen P, Morsett L, El Khoury J. Microglia in neurodegeneration. Nat Neurosci. 2018;21(10):1359-69.
38. Hambardzumyan D, Gutmann DH, Kettenmann H. The role of microglia and macrophages in glioma maintenance and progression. Nat Neurosci. 2016;19(1):20-7.
39. Keren-Shaul H, Spinrad A, Weiner A, Matcovitch-Natan O, Dvir-Szternfeld R, Ulland TK, et al. A Unique Microglia Type Associated with Restricting Development of Alzheimer's Disease. Cell. 2017;169(7):1276-90.e17.
40. Regen F, Hellmann-Regen J, Costantini E, Reale M. Neuroinflammation and Alzheimer's Disease: Implications for Microglial Activation. Curr Alzheimer Res. 2017;14(11):1140-8.
41. Schneider J, Karpf J, Beckervordersandforth R. Role of Astrocytes in the Neurogenic Niches. Methods Mol Biol. 2019;1938:19-33.
42. Franklin BS, Latz E, Schmidt FI. The intra- and extracellular functions of ASC specks. Immunol Rev. 2018;281(1):74-87.
43. Liu H, Sun Y, O'Brien JA, Franco-Barraza J, Qi X, Yuan H, et al. Necroptotic astrocytes contribute to maintaining stemness of disseminated medulloblastoma through CCL2 secretion. Neuro Oncol. 2019.